1. Home
  2. TIL vs GTE Comparison

TIL vs GTE Comparison

Compare TIL & GTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • GTE
  • Stock Information
  • Founded
  • TIL 2018
  • GTE 2003
  • Country
  • TIL United States
  • GTE Canada
  • Employees
  • TIL N/A
  • GTE N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • GTE Oil & Gas Production
  • Sector
  • TIL Health Care
  • GTE Energy
  • Exchange
  • TIL Nasdaq
  • GTE Nasdaq
  • Market Cap
  • TIL 177.1M
  • GTE 158.1M
  • IPO Year
  • TIL 2021
  • GTE N/A
  • Fundamental
  • Price
  • TIL $12.74
  • GTE $4.38
  • Analyst Decision
  • TIL Strong Buy
  • GTE
  • Analyst Count
  • TIL 5
  • GTE 0
  • Target Price
  • TIL $100.67
  • GTE N/A
  • AVG Volume (30 Days)
  • TIL 62.5K
  • GTE 671.6K
  • Earning Date
  • TIL 11-13-2025
  • GTE 10-30-2025
  • Dividend Yield
  • TIL N/A
  • GTE N/A
  • EPS Growth
  • TIL N/A
  • GTE N/A
  • EPS
  • TIL N/A
  • GTE N/A
  • Revenue
  • TIL N/A
  • GTE $611,444,000.00
  • Revenue This Year
  • TIL N/A
  • GTE $4.87
  • Revenue Next Year
  • TIL N/A
  • GTE $1.50
  • P/E Ratio
  • TIL N/A
  • GTE N/A
  • Revenue Growth
  • TIL N/A
  • GTE N/A
  • 52 Week Low
  • TIL $10.80
  • GTE $3.09
  • 52 Week High
  • TIL $42.79
  • GTE $8.19
  • Technical
  • Relative Strength Index (RSI)
  • TIL 31.33
  • GTE 56.39
  • Support Level
  • TIL $13.53
  • GTE $3.09
  • Resistance Level
  • TIL $16.00
  • GTE $4.52
  • Average True Range (ATR)
  • TIL 1.32
  • GTE 0.27
  • MACD
  • TIL -0.22
  • GTE 0.05
  • Stochastic Oscillator
  • TIL 7.95
  • GTE 89.86

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About GTE Gran Tierra Energy Inc.

Gran Tierra Energy Inc is an independent energy company. The company, along with its subsidiaries, is focused on oil and gas exploration and production, with assets in Colombia, Canada, and Ecuador. It produces oil, natural gas, and natural gas liquids. Gran Tierra has assembled a diversified, high-quality asset base that is fully operated in Colombia and Ecuador and partly in Canada. The company operates various blocks in Colombia and Ecuador, spanning three basins. It also has contiguous areas in Alberta, Canada, spanning various gross acres across the Western Canadian Sedimentary Basin. The company's reportable segments are Colombia, Ecuador, Canada, and Other. A majority of its revenue is derived from its operations in Colombia.

Share on Social Networks: